DFDADECENTRALIZED FRAMEWORK FOR DRUG ASSESSMENT

Lisinopril

Treatment used for 8 conditions

Total Trials
2,942
Total Participants
3250K
Avg Effectiveness
82%
Avg Safety Score
70%

Conditions Treated

Click on a condition to view detailed treatment information and clinical trial data.

Chronic kidney disease due to diabetes mellitus type 2
Effectiveness:90%
Safety:70%
Trials:1,000
Participants:2000K
Hypertension
Effectiveness:88%
Safety:70%
Trials:80
Participants:500K
Metabolic Syndrome
Effectiveness:75%
Safety:70%
Trials:1,000
Participants:300K
Ischemic heart disease
Effectiveness:80%
Safety:70%
Trials:11
Participants:150K
Chronic kidney disease due to diabetes mellitus type 1
Effectiveness:85%
Safety:70%
Trials:300
Participants:100K
Rheumatic heart disease
Effectiveness:85%
Safety:70%
Trials:1
Participants:100K
Acute glomerulonephritis
Effectiveness:80%
Safety:70%
Trials:400
Participants:50K
Alcoholic cardiomyopathy
Effectiveness:75%
Safety:70%
Trials:150
Participants:50K
DECENTRALIZED FRAMEWORK FOR DRUG ASSESSMENT

EVIDENCE-BASED TREATMENT INFORMATION

TREATMENTS

  • CONDITIONS
  • TREATMENTS
  • FIND TRIALS

ABOUT

  • ABOUT
  • RESEARCH & EVIDENCE
  • FAQ

CONTACT

hello@dfda.earth
dFDA.earth

EVIDENCE-BASED TREATMENT INFORMATION

PRIVACY POLICY•TERMS OF SERVICE
© 2025 Mike P. Sinn